|
시장보고서
상품코드
2040491
소 유전학 시장 규모, 점유율 및 동향 분석 : 리포트 유형, 동물별, 유통 채널별, 지역별 및 부문별 예측(2026-2033년)Bovine Genetics Market Size, Share & Trends Analysis Report Type, By Animal, By Distribution Channel, By Region, and Segment Forecasts, 2026 - 2033 |
||||||
소의 유전학 요약
세계의 소 유전학 시장 규모는 2025년에 39억 달러로 추계되며, 2033년까지 67억 달러에 달할 것으로 예측됩니다.
2026-2033년 CAGR 7.1%로 성장할 것으로 예상됩니다. 이 시장은 정부 프로그램의 증가, 유전학 개선을 위한 기술 발전, 지속가능성과 질병 저항성 가축에 대한 관심 증가로 인해 확대되고 있습니다.
민관 모두 인프라 구축, 자금 지원 및 대규모 육종 프로그램 시행을 통해 소의 유전학 시장을 크게 견인하고 있습니다. 인도에서는 '라슈트리야 고쿨 미션(Rashtriya Gokul Mission)', '전국 인공수정 프로그램(Nationwide Artificial Insemination Programme)', '가축 위생 및 질병 대책 프로그램(LHDCP)' 등 등의 시책으로 유전적 개량, 질병 대책, 생산성 향상에 박차를 가하고 있습니다. 또한 국경을 초월한 국가 간 협력도 시장 성장을 촉진하고 있습니다. 예를 들어 2026년 3월 Leads Genetics Pvt. Ltd.의 대규모 체외수정(IVF) 기반 배아 이식 구상은 제도적 지원이 확대되고 있음을 보여주었습니다. 이러한 협력적 노력으로 우수한 유전자를 광범위하게 도입할 수 있게 되어 시장 성장을 촉진하고 있습니다.
또한 생식 및 유전체 기술의 발전은 소 유전학 시장의 변화를 주도하는 주요 원동력이 되고 있습니다. 체외수정(IVF), 배아 이식, 유전체 선별, 성별 선별 정액 등의 기술을 통해 보다 빠르고 정확한 유전적 개량이 가능해졌습니다. 예를 들어 2026년 3월, Leads Genetics Pvt. Ltd.는 높은 성공률을 자랑하는 대규모 체외수정(IVF) 기반 배아 이식 프로그램을 실시하여 우유 생산성과 품종의 품질을 크게 향상시켰습니다. 또한 게놈칩(Gau Chip, Mahish Chip), 질병 저항성 마커 식별과 같은 혁신 기술이 유전적 가치가 높은 개체의 선발을 가속화하고 있습니다.
또한 지속가능한 축산과 질병 저항성에 대한 관심이 높아지는 것도 소 유전학 시장의 또 다른 주요 촉진요인으로 작용하고 있습니다. 정부와 연구기관은 사료 효율 향상, 메탄 배출량 감소, 질병 저항성 강화로 이어지는 유전적 형질을 우선순위에 두고 있습니다. LHDCP와 ICAR에 따라 진행되는 프로그램 중 일부는 질병 저항성 유전자 마커를 식별하고 결절성 피부병 등의 발생을 억제하기 위한 수의학 인프라 강화에 초점을 맞추고 있습니다. 마찬가지로 2025년 4월, 베조스 어스 펀드(Bezos Earth Fund)와 같은 조직이 자금을 지원하는 글로벌 구상은 기후 변화에 대한 영향을 완화하기 위해 저배출 소를 선별적으로 사육하는 것을 추진하고 있습니다. 이러한 노력은 동물의 건강과 생산성을 향상시키고, 환경 부하를 줄이며, 축산업을 글로벌 지속가능성 목표와 일치시키고, 첨단 가축 유전학 솔루션의 도입을 촉진하는 데 도움이 될 것입니다.
자주 묻는 질문
목차
제1장 조사 방법과 범위
제2장 개요
제3장 시장 : 변수, 동향, 범위
제4장 소 유전학 시장 : 유형별 추정·동향 분석
제5장 소 유전학 시장 : 동물별 추정·동향 분석
제6장 소 유전학 시장 : 유통 채널별 추정·동향 분석
제7장 소 유전학 시장 : 지역별 추정·동향 분석
제8장 경쟁 구도
KSA 26.06.02Bovine Genetics Market Summary
The global bovine genetics market size was estimated at USD 3.9 billion in 2025 and is projected to reach USD 6.7 billion by 2033, growing at a CAGR of 7.1% from 2026 to 2033. The market is advancing due to increasing initiatives and government programs, technological advancements to improve genetics, and growing focus on sustainability and disease-resistant livestock.
Rising public and private initiatives are significantly driving the bovine genetics market by strengthening infrastructure, funding, and large-scale implementation of breeding programs. In India, schemes such as the Rashtriya Gokul Mission, Nationwide Artificial Insemination Programme, and Livestock Health and Disease Control Programme (LHDCP) are accelerating genetic improvement, disease control, and productivity enhancement. In addition, collaborations between cross border nations propel market growth. For instance, in March 2026, the large-scale IVF-based embryo transfer initiative by Leads Genetics Pvt. Ltd. highlighted growing institutional support. These coordinated efforts are enabling widespread adoption of superior genetics favoring market growth.
In addition, advancements in reproductive and genomic technologies are a key driver of transformation in the bovine genetics market. Some of the technologies such as in-vitro fertilization (IVF), embryo transfer, genomic selection, and sex-sorted semen are enabling faster and more precise genetic gains. For instance, in March 2026, Leads Genetics Pvt. Ltd. conducted large-scale IVF-based embryo transfer programs with high success rates, significantly enhancing milk productivity and breed quality. In addition, innovations such as genomic chips (Gau Chip, Mahish Chip) and disease-resistance marker identification are accelerating selection of high genetic merit animals.
Furthermore, increasing emphasis on sustainable livestock production and disease resilience is another major driver in the bovine genetics market. Governments and research institutions are prioritizing genetic traits that improve feed efficiency, reduce methane emissions, and enhance disease resistance. Some of the programs under LHDCP and ICAR focus on identifying genetic markers for disease resistance and strengthening veterinary infrastructure to reduce outbreaks such as lumpy skin disease. Similarly, global initiatives funded by organizations like the Bezos Earth Fund in April 2025 are promoting selective breeding of low-emission cattle to mitigate climate impact. These efforts improve animal health and productivity, reduce the environmental footprint, align livestock production with global sustainability goals, and boost adoption of advanced bovine genetics solutions.
Global Bovine Genetics Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the bovine genetics market report based on type, animal, distribution channel and region.
- Type Outlook (Revenue, USD Million, 2021 - 2033)
- Assistive Reproduction Technologies
- Live Animals
- Genomic/ Genetic Testing
- Animal Outlook (Revenue, USD Million, 2021 - 2033)
- Cattle
- Others
- Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)
- Private
- Public
- Region Outlook (Revenue, USD Million, 2021 - 2033)
- North America
- U.S.
- Canada
- Mexico
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia Pacific
- Japan
- China
- India
- Australia
- Thailand
- South Korea
- Latin America
- Brazil
- Argentina
- Middle East & Africa
- South Africa
- UAE
- Saudi Arabia
- Kuwait
- Qatar
- Oman
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation and Scope
- 1.2. Segment Definitions
- 1.2.1. Type
- 1.2.2. Animal
- 1.2.3. Distribution Channel
- 1.3. Research Methodology
- 1.4. Information Procurement
- 1.4.1. Purchased Database
- 1.4.2. GVR's Internal Database
- 1.4.3. Secondary Sources
- 1.4.4. Primary Research
- 1.5. Information/Data Analysis
- 1.5.1. Data Analysis Models
- 1.6. Market Formulation & Validation
- 1.7. Model Details
- 1.7.1. Model 1: Commodity Flow Analysis
- 1.7.2. Model 2: Bottom-Up Analysis
- 1.7.3. Model 3 Multivariate Analysis
- 1.8. List of Secondary Sources
- 1.9. List of Abbreviations
- 1.10. Objectives
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.3. Competitive Insights
Chapter 3. Market Variable Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Ancillary/Related Market Outlook
- 3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.1.1. Increasing Initiatives and Government Programs
- 3.2.1.2. Technological Advancements to Improve Genetics
- 3.2.1.3. Growing Focus on Sustainability and Disease-Resistant Livestock
- 3.2.2. Market Restraint Analysis
- 3.2.2.1. High Cost of Advanced Genetic Technologies
- 3.2.2.2. Limited Awareness and Infrastructure in Developing Regions
- 3.2.3. Market Opportunity Analysis
- 3.2.4. Market Challenge Analysis
- 3.2.1. Market Driver Analysis
- 3.3. Estimated Animal Population by Key Species & Key Countries, 2025
- 3.4. Technology Trend Analysis
- 3.5. Pricing Analysis
- 3.6. Market Analysis Tools
- 3.6.1. Porter's Five Forces Analysis
- 3.6.2. PESTEL by SWOT Analysis
Chapter 4. Bovine Genetics Market: By Type Estimates & Trend Analysis
- 4.1. Bovine Genetics Market, By Type: Segment Dashboard
- 4.2. Bovine Genetics Market, By Type Movement Analysis
- 4.3. Bovine Genetics Market Estimates & Forecasts, by Type, 2021 to 2033 (USD Million)
- 4.4. Assistive Reproduction Technologies
- 4.4.1. Assistive Reproduction Technologies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.5. Live Animals
- 4.5.1. Live Animals Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.6. Genomic/ Genetic Testing
- 4.6.1. Genomic/ Genetic Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 5. Bovine Genetics Market: By Animal Estimates & Trend Analysis
- 5.1. Bovine Genetics Market, By Animal: Segment Dashboard
- 5.2. Bovine Genetics Market, By Animal Movement Analysis
- 5.3. Bovine Genetics Market Estimates & Forecasts, by Animal, 2021 to 2033 (USD Million)
- 5.4. Cattle
- 5.4.1. Cattle Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.5. Others
- 5.5.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 6. Bovine Genetics Market: By Distribution Channel Estimates & Trend Analysis
- 6.1. Bovine Genetics Market, By Distribution Channel: Segment Dashboard
- 6.2. Bovine Genetics Market, By Distribution Channel Movement Analysis
- 6.3. Bovine Genetics Market Estimates & Forecasts, by Distribution Channel, 2021 to 2033 (USD Million)
- 6.4. Private
- 6.4.1. Private Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.5. Public
- 6.5.1. Public Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 7. Bovine Genetics Market: By Regional Estimates & Trend Analysis
- 7.1. Region Market Dashboard
- 7.2. Region Market Share Analysis, 2025 & 2033
- 7.3. North America
- 7.3.1. North America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.3.2. U.S
- 7.3.2.1. Key Country Dynamics
- 7.3.2.2. Competitive Scenario
- 7.3.2.3. Regulatory Framework
- 7.3.2.4. U.S. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.3.3. Canada
- 7.3.3.1. Key Country Dynamics
- 7.3.3.2. Competitive Scenario
- 7.3.3.3. Regulatory Framework
- 7.3.3.4. Canada Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.3.4. Mexico
- 7.3.4.1. Key Country Dynamics
- 7.3.4.2. Competitive Scenario
- 7.3.4.3. Regulatory Framework
- 7.3.4.4. Mexico Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.4. Europe
- 7.4.1. Europe Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.4.2. UK
- 7.4.2.1. Key Country Dynamics
- 7.4.2.2. Competitive Scenario
- 7.4.2.3. Regulatory Framework
- 7.4.2.4. UK Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.4.3. Germany
- 7.4.3.1. Key Country Dynamics
- 7.4.3.2. Competitive Scenario
- 7.4.3.3. Regulatory Framework
- 7.4.3.4. Germany Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.4.4. France
- 7.4.4.1. Key Country Dynamics
- 7.4.4.2. Competitive Scenario
- 7.4.4.3. Regulatory Framework
- 7.4.4.4. France Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.4.5. Italy
- 7.4.5.1. Key Country Dynamics
- 7.4.5.2. Competitive Scenario
- 7.4.5.3. Regulatory Framework
- 7.4.5.4. Italy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.4.6. Spain
- 7.4.6.1. Key Country Dynamics
- 7.4.6.2. Competitive Scenario
- 7.4.6.3. Regulatory Framework
- 7.4.6.4. Spain Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.4.7. Denmark
- 7.4.7.1. Key Country Dynamics
- 7.4.7.2. Competitive Scenario
- 7.4.7.3. Regulatory Framework
- 7.4.7.4. Denmark Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.4.8. Sweden
- 7.4.8.1. Key Country Dynamics
- 7.4.8.2. Competitive Scenario
- 7.4.8.3. Regulatory Framework
- 7.4.8.4. Sweden Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.4.9. Norway
- 7.4.9.1. Key Country Dynamics
- 7.4.9.2. Competitive Scenario
- 7.4.9.3. Regulatory Framework
- 7.4.9.4. Norway Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.5. Asia Pacific
- 7.5.1. Asia Pacific Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.5.2. Japan
- 7.5.2.1. Key Country Dynamics
- 7.5.2.2. Competitive Scenario
- 7.5.2.3. Regulatory Framework
- 7.5.2.4. Japan Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.5.3. China
- 7.5.3.1. Key Country Dynamics
- 7.5.3.2. Competitive Scenario
- 7.5.3.3. Regulatory Framework
- 7.5.3.4. China Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.5.4. India
- 7.5.4.1. Key Country Dynamics
- 7.5.4.2. Competitive Scenario
- 7.5.4.3. Regulatory Framework
- 7.5.4.4. India Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.5.5. Australia
- 7.5.5.1. Key Country Dynamics
- 7.5.5.2. Competitive Scenario
- 7.5.5.3. Regulatory Framework
- 7.5.5.4. Australia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.5.6. Thailand
- 7.5.6.1. Key Country Dynamics
- 7.5.6.2. Competitive Scenario
- 7.5.6.3. Regulatory Framework
- 7.5.6.4. Thailand Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.5.7. South Korea
- 7.5.7.1. Key Country Dynamics
- 7.5.7.2. Competitive Scenario
- 7.5.7.3. Regulatory Framework
- 7.5.7.4. South Korea Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.6. Latin America
- 7.6.1. Latin America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.6.2. Brazil
- 7.6.2.1. Key Country Dynamics
- 7.6.2.2. Competitive Scenario
- 7.6.2.3. Regulatory Framework
- 7.6.2.4. Brazil Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.6.3. Argentina
- 7.6.3.1. Key Country Dynamics
- 7.6.3.2. Competitive Scenario
- 7.6.3.3. Regulatory Framework
- 7.6.3.4. Argentina Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.7. MEA
- 7.7.1. MEA Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.7.2. South Africa
- 7.7.2.1. Key Country Dynamics
- 7.7.2.2. Competitive Scenario
- 7.7.2.3. Regulatory Framework
- 7.7.2.4. South Africa Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.7.3. UAE
- 7.7.3.1. Key Country Dynamics
- 7.7.3.2. Competitive Scenario
- 7.7.3.3. Regulatory Framework
- 7.7.3.4. UAE Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.7.4. Saudi Arabia
- 7.7.4.1. Key Country Dynamics
- 7.7.4.2. Competitive Scenario
- 7.7.4.3. Regulatory Framework
- 7.7.4.4. Saudi Arabia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.7.5. Kuwait
- 7.7.5.1. Key Country Dynamics
- 7.7.5.2. Competitive Scenario
- 7.7.5.3. Regulatory Framework
- 7.7.5.4. Kuwait Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.7.6. Qatar
- 7.7.6.1. Key Country Dynamics
- 7.7.6.2. Competitive Scenario
- 7.7.6.3. Regulatory Framework
- 7.7.6.4. Qatar Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.7.7. Oman
- 7.7.7.1. Key Country Dynamics
- 7.7.7.2. Competitive Scenario
- 7.7.7.3. Regulatory Framework
- 7.7.7.4. Oman Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 8. Competitive Landscape
- 8.1. Market Participant Categorization
- 8.1.1. Market Leaders
- 8.1.2. Emerging Players
- 8.2. Market Share/Assessment Analysis, 2025 (Heat Map Analysis)
- 8.3. Company Profiles
- 8.3.1. Neogen Corporation
- 8.3.1.1. Participant's Overview
- 8.3.1.2. Financial Performance
- 8.3.1.3. Product/Service Benchmarking
- 8.3.1.4. Strategic Initiatives
- 8.3.2. Genetics Australia
- 8.3.2.1. Participant's Overview
- 8.3.2.2. Financial Performance
- 8.3.2.3. Product/Service Benchmarking
- 8.3.2.4. Strategic Initiatives
- 8.3.3. Genus plc
- 8.3.3.1. Participant's Overview
- 8.3.3.2. Financial Performance
- 8.3.3.3. Product/Service Benchmarking
- 8.3.3.4. Strategic Initiatives
- 8.3.4. Zoetis Services LLC
- 8.3.4.1. Participant's Overview
- 8.3.4.2. Financial Performance
- 8.3.4.3. Product/Service Benchmarking
- 8.3.4.4. Strategic Initiatives
- 8.3.5. Semex
- 8.3.5.1. Participant's Overview
- 8.3.5.2. Financial Performance
- 8.3.5.3. Product/Service Benchmarking
- 8.3.5.4. Strategic Initiatives
- 8.3.6. CRV
- 8.3.6.1. Participant's Overview
- 8.3.6.2. Financial Performance
- 8.3.6.3. Product/Service Benchmarking
- 8.3.6.4. Strategic Initiatives
- 8.3.7. URUS Group LP
- 8.3.7.1. Participant's Overview
- 8.3.7.2. Financial Performance
- 8.3.7.3. Product/Service Benchmarking
- 8.3.7.4. Strategic Initiatives
- 8.3.8. STgenetics
- 8.3.8.1. Participant's Overview
- 8.3.8.2. Financial Performance
- 8.3.8.3. Product/Service Benchmarking
- 8.3.8.4. Strategic Initiatives
- 8.3.9. Agri-Gene
- 8.3.9.1. Participant's Overview
- 8.3.9.2. Financial Performance
- 8.3.9.3. Product/Service Benchmarking
- 8.3.9.4. Strategic Initiatives
- 8.3.10. Bovine Genetics
- 8.3.10.1. Participant's Overview
- 8.3.10.2. Financial Performance
- 8.3.10.3. Product/Service Benchmarking
- 8.3.10.4. Strategic Initiatives
- 8.3.1. Neogen Corporation
